TMPRSS2 and neoplasm: While suppression of this process with J54-mediated inhibition of pY407 results in complete tumor regression for the LNCaP xenograft model [24], the VCaP xenografts, additionally dependent on the ERG-TMPRSS2 oncogenic translocation, are partly resistant to the combined treatment of ENZ+J54 (which normally results in apoptosis).